Review of magnetic nanostructures grown by focused electron beam induced deposition (FEBID)
…, A Fernández-Pacheco, R Córdoba… - Journal of Physics D …, 2016 - iopscience.iop.org
We review the current status of the use of focused electron beam induced deposition (FEBID)
for the growth of magnetic nanostructures. This technique relies on the local dissociation of …
for the growth of magnetic nanostructures. This technique relies on the local dissociation of …
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic …
ESC Guidelines e341 (1) the specific situation of the patient. In this respect, it is specified that,
unless otherwise provided for by national regulations, offlabel use of medication should be …
unless otherwise provided for by national regulations, offlabel use of medication should be …
Immunotherapy in older adults with advanced cancers: implications for clinical decision-making and future research
R Kanesvaran, R Cordoba, R Maggiore - American Society of Clinical …, 2018 - ascopubs.org
Immunotherapy has expanded the therapeutic landscape for advanced cancers, including
solid tumors and lymphomas. For many patients with cancer, these agents have been shown …
solid tumors and lymphomas. For many patients with cancer, these agents have been shown …
Outcomes of COVID-19 in patients with CLL: a multicenter international experience
…, SS Skånland, R Cordoba… - Blood, The Journal …, 2020 - ashpublications.org
Given advanced age, comorbidities, and immune dysfunction, chronic lymphocytic leukemia
(CLL) patients may be at particularly high risk of infection and poor outcomes related to …
(CLL) patients may be at particularly high risk of infection and poor outcomes related to …
[HTML][HTML] Frailty assessment in the care of older people with haematological malignancies
…, FJ Martinez-Peromingo, R Cordoba - The Lancet Healthy …, 2021 - thelancet.com
… In these studies, these three tools were predictive of inferior outcomes after treatment of
non-Hodgkin lymphoma with chemoimmunotherapy plus lenalidomide or R-CHOP (rituximab …
non-Hodgkin lymphoma with chemoimmunotherapy plus lenalidomide or R-CHOP (rituximab …
[HTML][HTML] COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study
…, D Bron, A Capasso, S Chatzileontiadou, R Cordoba… - Leukemia, 2021 - nature.com
Patients with chronic lymphocytic leukemia (CLL) may be more susceptible to Coronavirus
disease 2019 (COVID-19) due to age, disease, and treatment-related immunosuppression. …
disease 2019 (COVID-19) due to age, disease, and treatment-related immunosuppression. …
Safety and activity of ibrutinib in combination with nivolumab in patients with relapsed non-Hodgkin lymphoma or chronic lymphocytic leukaemia: a phase 1/2a study
…, M Yağci, NA Horowitz, P Marlton, R Cordoba… - The Lancet …, 2019 - thelancet.com
Background Preclinical studies have shown synergistic antitumour effects between ibrutinib
and immune-checkpoint blockade. The aim of this study was to assess the safety and activity …
and immune-checkpoint blockade. The aim of this study was to assess the safety and activity …
Outcome of infection with omicron SARS‐CoV‐2 variant in patients with hematological malignancies: an EPICOVIDEHA survey report
…, M Sciumè, E Ammatuna, R Cordoba… - American journal of …, 2022 - Wiley Online Library
To the Editor: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has
caused high mortality in patients with hematological malignancies (HM). 1 The newly …
caused high mortality in patients with hematological malignancies (HM). 1 The newly …
Stigma and functioning in patients with bipolar disorder
…, F Kapczinski, PV Magalhaes, R Córdoba… - Journal of affective …, 2011 - Elsevier
OBJECTIVE: The aim of this study was to investigate the impact of self-rated stigma and
functioning in patients with bipolar disorder in Latin-America. METHODS: Two-hundred and forty-…
functioning in patients with bipolar disorder in Latin-America. METHODS: Two-hundred and forty-…
COVID-19 in patients with CLL: improved survival outcomes and update on management strategies
COI notes: LER has served as a consultant for AbbVie, AstraZeneca, Pharmacyclics, Vaniam
group, and Verastem, holds minority ownership interest in Abbott Laboratories, and has …
group, and Verastem, holds minority ownership interest in Abbott Laboratories, and has …